The record
| Class | anti aging |
|---|---|
| Also known as | AEDG peptide, Epitalon, Epithalamin synthetic, Epithalone |
| Chain length | - |
| Molecular weight | 390.3 Da |
| Half-life | ~30 minutes |
| Route | SC or IM |
| Studied for | - |
| Research use | Telomerase activation studies; Aging research; Circadian rhythm studies |
| What has been shown | Increased telomerase activity; Extended lifespan in animal models; Improved circadian rhythms; Reduced age-related biomarkers |
| How it works | Synthetic tetrapeptide based on epithalamin (pineal extract). Primary mechanism: telomerase activation. Increases telomerase activity in somatic cells, potentially extending replicative lifespan. Also: (1) Regulates melatonin production, (2) Normalizes circadian rhythms, (3) Antioxidant effects, (4) Modulates neuroendocrine system. May activate gene expression through epigenetic mechanisms. |
| Patent status | St. Petersburg Institute |
| Regulatory status | Research only |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Sleep Optimization (affection, 30%)
- Circadian Rhythm Alignment (affection, 50%)
- Oxidative Stress Resilience (affection, 42%)
- Telomere-associated Research Environment (affection, 79%)
- Acetaminophen toxicity (illness, 30%)
- Antioxidant supplementation (illness, 30%)
- Detoxification support (illness, 30%)
- Erythropoietic protoporphyria - FDA approved (illness, 30%)
- Polymorphous light eruption (illness, 30%)
- Skin lightening (illness, 30%)
- Solar urticaria (illness, 30%)
- Vitiligo (illness, 30%)
- Poor sleep (symptom, 33%)